Cambridge
Principal Investigator: Professor David Neal
Professor David Neal moved to Cambridge in 2002 to establish a new clinical department and a translational research programme into prostate cancer. The clinical department has a fully comprehensive range of treatments for urological cancer and in particular for prostate cancer. The department has a large experience of Da Vinci Robotic prostatectomy too.
The research programme is described in more detail overleaf but ranges from Phase III clinical trials through short cohort translational studies through to laboratory based programmes of biomarker discovery and validation.
Grants & Funding Information
2006) Joint grant with Southern Collaborative (Eeles R, Easton D) Whole genome study for prostate cancer susceptibility alleles. CR UK. (total £4M)
2007) ProtecT extension. Donovan JL, Hamdy FC, and Neal DE. NHS HTA.
2007) HEFCE Funding for Mr Vincent Gnanapragasam as SL (£250k).
2007) Three Academic appointment as ACF and CL level for next 5 years from NCCRCD (£250k)
2008) Joint project with Philips Medical on proteomics in prostate cancer (£300k)
2008) PROMARK. FP7 funding for study of prostate cancer (£300k)
2008) Clinical PhD Studentship for Alastair Lamb (GSK) (£150k).
2008) Clinical PhD Studentship for Naomi Tyreman (CR UK; £150k)
